Cargando…
CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
Autores principales: | Chakravorty, Shourjo, Cochrane, Adam B., Psotka, Mitchell A., Regmi, Anil, Marinak, Lauren, Thatcher, Amy, Shlobin, Oksana A., Brown, A. Whitney, King, Christopher S., Ahmad, Kareem, Khangoora, Vikramjit, Singhal, Anju, Nathan, Steven D., Aryal, Shambhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191559/ https://www.ncbi.nlm.nih.gov/pubmed/35706606 http://dx.doi.org/10.1097/TXD.0000000000001344 |
Ejemplares similares
-
COURSE AND OUTCOMES OF COVID-19 INFECTIONS IN LUNG TRANSPLANT RECIPIENTS
por: NYQUIST, ALAN S, et al.
Publicado: (2022) -
Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
por: Chandel, Abhimanyu, et al.
Publicado: (2021) -
Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
por: Limaye, Ajit P., et al.
Publicado: (2020) -
Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis
por: Thomas, Christopher, et al.
Publicado: (2023) -
A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)